Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma

201924 citationsJournal Articlehybrid Open Access

Authors

Paul Turner · Public Health England

Louise Fleming · Imperial College London

Sejal Saglani · Imperial College London

Jo Southern · Public Health England

Nick Andrews · Public Health England

Elizabeth Miller · Public Health England

Alexandra Adams

Abstract

LAIV appears to be well tolerated in the vast majority of children with asthma or recurrent wheeze, including those whose asthma is categorized as severe or poorly controlled.

Topics & Keywords

Asthma and respiratory diseases Respiratory and Cough-Related Research Respiratory viral infections research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Allergy and Clinical Immunology

Volume 145, Issue 4, pp. 1157-1164.e6

DOI: 10.1016/j.jaci.2019.12.010

Field-Weighted Citation Impact: 1.83